CRIS Quote, Trading Chart, Curis Inc.
home / stock / cris / cris quote
$7.61 Last:
0.93% Change Percent:
$7.57 Open:
$7.61 Previous Close:
$8.0151 High:
$7.51 Low:
3,637,619 Volume:
06/21/2021 04:42:46 am Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
CRIS Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-06-21 | 7.57 | 7.61 | 8.0151 | 7.51 | 3,637,619 |
| 2021-06-18 | 7.56 | 7.54 | 7.6982 | 7.41 | 4,773,080 |
| 2021-06-17 | 7.49 | 7.63 | 7.8 | 7.351 | 3,633,233 |
| 2021-06-16 | 7.6 | 7.58 | 7.87 | 7.41 | 4,492,102 |
| 2021-06-15 | 8.02 | 7.61 | 8.05 | 7.57 | 4,808,185 |
| 2021-06-14 | 8.29 | 8.07 | 8.65 | 8 | 6,314,142 |
| 2021-06-11 | 9.66 | 8.01 | 9.7 | 7.6 | 21,468,224 |
| 2021-06-10 | 13.1 | 12.68 | 13.1864 | 12.3 | 3,190,529 |
| 2021-06-09 | 13.92 | 13 | 14.28 | 12.88 | 1,822,537 |
| 2021-06-08 | 14.8939 | 14.04 | 15.6 | 13.85 | 2,274,151 |
| 2021-06-07 | 14.53 | 14.66 | 14.8999 | 14.06 | 2,449,270 |
| 2021-06-04 | 14.59 | 14.37 | 14.79 | 14.33 | 781,405 |
| 2021-06-03 | 14.24 | 14.49 | 14.65 | 14.24 | 886,874 |
| 2021-06-02 | 14.61 | 14.47 | 14.88 | 14.325 | 1,311,959 |
| 2021-06-01 | 14.61 | 14.41 | 15.1 | 14.33 | 1,387,393 |
| 2021-05-31 | 14.17 | 14.4 | 14.78 | 14.1 | 1,460,510 |
| 2021-05-28 | 14.17 | 14.4 | 14.78 | 14.1 | 1,459,675 |
| 2021-05-27 | 14 | 13.95 | 14.0199 | 13.69 | 2,376,792 |
| 2021-05-26 | 13.83 | 13.82 | 14.0577 | 13.77 | 868,244 |
| 2021-05-25 | 14.08 | 13.67 | 14.45 | 13.63 | 813,559 |
News, Short Squeeze, Breakout and More Instantly...
-
Curis Doses First Patient in Phase 1 Study of CA-4948 in Combination with Ibrutinib in Patients with Relapsed or Refractory Hematologic Malignancies - Amends existing protocol of ongoing Phase 1 study in R/R NHL - - Initial data expected in the fourth quarter of 2021 - P...
-
Curis Announces Initiation of Investigator-Sponsored Phase 2 LUCAS Study of CA-4948 for the Treatment of Anemia in Patients with Very Low, Low, or Intermediate-Risk Myelodysplastic Syndromes - Phase 2 study sponsored by investigators at Universität Leipzig in Germany - ...
-
Curis to Present at B. Riley Securities Virtual Oncology Investor Conference PR Newswire LEXINGTON, Mass. , Jan. 14, 2021 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment o...